Table 4

Clinical Characteristics and therapy according to stroke subtypes
Ischemic Hemorrhagic Not identified P-value
No (%) 29(52%) 19 (34%) 8(14%)
Age 60.5 ± 12 60 ± 11 67 ± 15 0.41
Gender Female 10(34.5) 2(10.5) 2(25) 0.17
Diabetes Mellitus 16(52.2) 7(36.8) 1(12.5) 0.08
Hypertension 20(69) 9(47.4) 6(75) 0.23
Atrial fibrillation 4(13.8) 0(0) 0(0) 0.14
Heart rate 92 ± 19 89.9 ± 15 83 ± 30 0.54
Systolic blood pressure 132 ± 30 139 ± 35 116 ± 50 0.29
Diastolic blood pressure 76 ± 24 84 ± 19 68 ± 32 0.28
STEMI 20(69) 16(84.2) 4(50)
NSTEMI 6(20.7) 1(5.3) 3(37.5)
UA 3(0.3) 2(10.5) 1(12.5) 0.34
Coronary Angiogram 5(17.2) 1(5.3) 1(12.5) 0.30
PCI 2(6.9) 1(5.3) 0(0) 0.47
Medications on admission
Thrombolytic therapy 10(52.6) 5(31.2) 0(0) 0.11
Glycoprotein IIb/III inhibitors 12(41.4) 7(36.8) 6(75) 0.17
aspirin 26(89.7) 17(89.5) 8(100) 0.63
Clopidogrel 15(51.7) 6(31.6) 4(50) 0.37

Al Suwaidi et al.

Al Suwaidi et al. BMC Cardiovascular Disorders 2012 12:64   doi:10.1186/1471-2261-12-64

Open Data